Pediatrics
Latest News
Apremilast alleviates severe psoriasis in some children, data show
“In this randomized, placebo-controlled trial, oral apremilast demonstrated effectiveness and was well tolerated.”
Livin' on the MDedge
‘Dr. Caveman’ had a leg up on amputation
Plus: Walking your way to a quieter baby, lending a nose to Parkinson’s research, and identifying the office flirts.
20th Anniversary
OMERACT continues to set standards on research outcomes, enhancing the patient voice
OMERACT arose from a need to streamline clinical outcome measures in rheumatology, and now with 30 years of...
Latest News
VTE risk not elevated in AD patients on JAK inhibitors: Study
The labels of JAK inhibitors include a boxed warning describing an increased risk of “serious heart-related events such as heart attack or stroke...
News from the FDA/CDC
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
The 100-mg/mL version of adalimumab-bwwd (Hadlima) is indicated for the same seven conditions as its 50-mg/mL counterpart.
From the Journals
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
While switches between biosimilars of the same reference biologic already occur for biosimilars with indications in different specialties, they do...
Latest News
Experts: EPA should assess risk of sunscreens’ UV filters
The assessment is urgently needed and the results should be shared with the Food and Drug Administration, the experts said.
From the Journals
Stopping JIA drugs? Many can regain control after a flare
About 67% of patients who stopped medications for well-controlled JIA got their condition under control by 1 year after postflare treatment,...
Guidelines
ACR makes changes to adult, pediatric vaccinations guidance
The pneumococcal, recombinant zoster, and HPV vaccines are among those recommended for patients taking immunosuppressive medications.
News from the FDA/CDC
Ustekinumab becomes second biologic approved for PsA in kids
The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to...
News from the FDA/CDC
FDA approves belimumab for children with lupus nephritis
Children with lupus-related kidney damage can now receive the B cell–reducing therapy that adults with lupus nephritis have been able to get for...